Cape Girardeau, Missouri news highlights UC clinical trial

Study to test neurostimulation to treat opioid withdrawal, PTSD

KFVS-TV in Cape Girardeau, Missouri highlighted a University of Cincinnati clinical trial testing a wearable neurostimulation device to help patients with opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) stick with medication treatment while finding the right dose.

UC's Joel Sprunger, principal investigator of the trial, said the medication buprenorphine is an effective treatment to help patients with OUD manage symptoms of opioid use disorder withdrawal, but there is an adjustment period of up to three months as each patient finds the right dose to manage their symptoms.

In response to this challenge, the trial will utilize the Sparrow Ascent – a patient-administered wearable device that delivers mild electrical stimulation to the cranial branches of the vagus and trigeminal nerves on and around the ear. 

Sprunger said the stimulation “pumps the brakes” on the sympathetic nervous system by enhancing parasympathetic activity, helping to transition someone from fight-or-flight to “rest and digest.”

“By providing people control over that stimulation, we can empower them with a way to turn it on when needed and feel some relief,” said Sprunger, assistant professor of psychiatry and behavioral neuroscience in UC’s College of Medicine. “Their heart rate slows down, breathing slows down and there’s a lot less of a sense of panic and urgency. So that’s the key ingredient that we think will hit both PTSD and opioid withdrawal symptoms at the same time.”  

The trial is enrolling patients at the Gibson Center for Behavioral Change in Cape Girardeau. 

“It does give the patient some ownership and some control over their treatment,” Ryan Essex, Gibson Center chief operating officer, told KFVS. "We get to bring cutting edge treatment options to populations who are kind of our most vulnerable and don’t get access to those."

Watch or read the KFVS story.

NeuroNews also highlighted the trial. Read the NeuroNews story.

Read more about the trial.

Featured photo at top of woman wearing the Sparrow Ascent device. Photo/Spark Biomedical.

Related Stories

9963 Results
3

Camp aims to empower children, teens who stutter

July 17, 2024

A one-week, evidence-based program for children and teens who stutter at the University of Cincinnati will teach kids to communicate effectively, advocate for themselves and develop confidence about their communication abilities. Camp Dream. Speak. Live., which is coming to Cincinnati for the first time July 22-26, began in 2014 at the University of Texas at Austin. The Arthur M. Blank Center for Stuttering Education and Research at UT expects to serve more than 2,000 children at camps across the United States, Africa, Asia and Europe this year.

7

U.S. stroke survival is improving, but race still plays role

July 16, 2024

U.S. News & World Report, HealthDay and Real Health covered new research from the University of Cincinnati that found overall rates of long-term survival following stroke are improving, but Black individuals experience worse long-term outcomes compared to white individuals.

8

Collaborative pianist and vocal coach Kirill Kuzmin joins CCM’s faculty

July 16, 2024

UC College-Conservatory of Music Interim Dean Jonathan Kregor has announced the addition of Kirill Kuzmin to the college’s faculty of distinguished performing and media arts experts, researchers and educators. A Grammy-nominated collaborative pianist and vocal coach, Kuzmin begins his new role as Associate Professor of Opera/Vocal Coaching on Aug. 15, 2024.

10

Presidential challenge to UC: Join Ride Cincinnati to fight cancer

July 16, 2024

UC President Neville Pinto has again challenged every UC college and unit to send at least one rider to the September 14 Ride Cincinnati event to help fundraise for cancer research and cancer care. UC students ride free. Signup by July 31 for free UC-branded cycling jersey.